Author

Ahmed S. Alanazi

Observed name: Ahmed S Alanazi

Institution: King Fahd Medical City

Observed institution: King Fahd Medical City

ORCID: 0000-0001-7784-3848

Observed ORCID: 0000-0001-7784-3848

OpenAlex ID: A5133758131

Impact of Leucovorin Shortage: A Comparison of Standard-Dose Versus Reduced-Dose Leucovorin in Metastatic Colorectal Cancer

2026 · Jude Howaidi, Fouad Alnajjar, et al. · JCO Global Oncology

Association of baseline serum albumin with treatment-related toxicities in patients receiving tyrosine kinase inhibitors: a real-world cohort study

2026 · Ahmed S. Alanazi, Mohammed Alnuhait, et al. · BMC Cancer

Estimating the budget impact of introducing dostarlimab as first line in treating endometrial cancer in Saudi Arabia

2026 · Mohamed Aseafan, Faisal Azam, et al. · Journal of Medical Economics

Clinical utility of the HFA-ICOS risk tool in real-world HER2-positive breast cancer patients receiving therapy

2026 · Lama Alfehaid, Nada Alsuhebany, et al. · Cardio-Oncology

Expert consensus on the role of immunotherapy in nasopharyngeal carcinoma: clinical and economic perspectives from the GCC region

2026 · Anas Hamad, Ahmed El-Sheashaey, et al. · Expert Review of Anticancer Therapy

Real-World Outcomes of Palbociclib with Endocrine Therapy in HR+/HER2− Metastatic Breast Cancer: A Retrospective Study from Saudi Arabia

2026 · Abdalrhman H. Alanizi, Sarah N. Al-Shaiban, et al. · Cancers

Works count: 6

Citation count:

H-index:

I10-index: